MAIA
MAIA Biotechnology, Inc.Company Information
- Company Name
- MAIA Biotechnology, Inc.
- CIK
- CIK0001878313
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- MAIA: NYSE
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- MAIA
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-09-14
- Last sale
- —
- Shares purchased (TTM)
- 661,960
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 13,524,806
- Shares outstanding
- 60,794,335
- Ownership
- 22.25%
Earnings Market Reaction
- Filing date
- 2026-08-10
- Price on filing date
- —
- 1-month reaction
- -6.38%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash | 28 | 34 | 9 | 11 | 10 | 11 | 10 | 9 | 12 | 8 | 7 | 6 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 28 | 35 | 10 | 12 | 11 | 12 | 10 | 9 | 12 | 9 | 8 | 7 | ||||||
| Prepaid Expense And Other Assets Current | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Costs | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets | 28 | 35 | 10 | 12 | 11 | 12 | 10 | 9 | 12 | 9 | 8 | 7 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 3 | 3 | 2 | 3 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 6 | 6 | 6 | 10 | 5 | 5 | 4 | 4 | 4 | 5 | 5 | 4 | ||||||
| Accrued Liabilities Current | 3 | 3 | 4 | 7 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 3 | ||||||
| Derivative Liabilities Noncurrent | 1 | 1 | 1 | 2 | 2 | - | 3 | - | - | - | - | - | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Liabilities | 8 | 8 | 7 | 12 | 7 | 7 | 7 | 8 | 9 | 14 | 7 | 4 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 145 | 144 | 112 | 106 | 101 | 97 | 91 | 85 | 84 | 66 | 64 | 61 | ||||||
Stockholders Equity | ||||||||||||||||||
| Stockholders Equity | 21 | 28 | 2 | 0 | 4 | 5 | 4 | 2 | 3 | -6 | 0 | 3 | ||||||
| Retained Earnings Accumulated Deficit | -124 | -116 | -110 | -106 | -97 | -92 | -87 | -84 | -81 | -72 | -64 | -58 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 28 | 35 | 10 | 12 | 11 | 12 | 10 | 9 | 12 | 9 | 8 | 7 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 150 | 150 | 150 | 150 | 150 | 70 | 70 | 70 | 70 | 70 | 70 | 70 | ||||||
| Common Stock Shares Issued | 61 | 61 | 39 | 34 | 32 | 30 | 26 | 24 | 24 | 21 | 17 | 14 | ||||||
| Shares Outstanding | 61 | 61 | 39 | 34 | 32 | 30 | 26 | 24 | 24 | 21 | 17 | 14 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMAIA Biotechnology, Inc. (MAIA) — SEC Financial Statements & Analysis
MAIA Biotechnology, Inc. (MAIA) is a pharmaceutical preparations company, incorporated in DE. MAIA Biotechnology, Inc. trades on NYSE as: MAIA. MAIA Biotechnology, Inc. (MAIA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10. Based on that filing, MAIA Biotechnology, Inc. carries a market cap of $87.54M, a P/E ratio of -3.26x, a P/B ratio of 4.23x, an enterprise value of $59.95M, and an EV/EBITDA multiple of -2.07x. On profitability, it posts a Return on Equity (ROE) of -218.68% and a Return on Assets (ROA) of -136.67%. Per share, it reports EPS of $-0.44, diluted EPS of $-0.44, free cash flow per share of $-0.37, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 66.00% year-over-year and EPS growth of -17.27% year-over-year. On the balance sheet, it maintains a current ratio of 4.51x, a quick ratio of 4.41x, working capital of $21.98M, a debt-to-equity ratio of 0.37x, a debt ratio of 0.27, an interest coverage ratio of -891322.11x, free cash flow of $-22.57M (TTM), and net debt of $-27.60M. Figures sourced from SEC EDGAR.
- Market Cap
- $87.54M
- P/E TTM
- -3.26x
- EPS TTM
- $-0.44
- P/B TTM
- 4.23x
- ROE TTM
- -218.68%
- ROA TTM
- -136.67%
- Debt To Equity
- 0.37x
- Free Cash Flow TTM
- $-22.57M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MAIA Biotechnology, Inc. in?
MAIA Biotechnology, Inc. (MAIA) operates in the Pharmaceutical Preparations industry.
What exchange does MAIA trade on?
MAIA Biotechnology, Inc. (MAIA) trades on the NYSE.
Where is MAIA Biotechnology, Inc. incorporated?
MAIA Biotechnology, Inc. is incorporated in DE.
When was MAIA Biotechnology, Inc. (MAIA)'s most recent SEC filing?
MAIA Biotechnology, Inc. (MAIA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-10.
What is MAIA's market cap?
MAIA Biotechnology, Inc. (MAIA) has a market capitalization of $87.54M as of 2026-06-30.
What is MAIA's EPS (earnings per share)?
MAIA Biotechnology, Inc. (MAIA)'s trailing twelve month EPS is $-0.44 as of 2026-06-30.
What is MAIA's ROE (return on equity)?
MAIA Biotechnology, Inc. (MAIA)'s trailing twelve month Return on Equity (ROE) is -218.68% as of 2026-06-30.
What is MAIA's ROA (return on assets)?
MAIA Biotechnology, Inc. (MAIA)'s trailing twelve month Return on Assets (ROA) is -136.67% as of 2026-06-30.
What is MAIA's EV/EBITDA?
MAIA Biotechnology, Inc. (MAIA)'s trailing twelve month EV/EBITDA is -2.07x as of 2026-06-30.